Home » Topics » BioWorld Science

BioWorld Science
RSS

Vertex Pharmaceuticals patents CFTR potentiators

April 29, 2022

University of California discloses new PRMT8 inhibitors

April 29, 2022

ProfoundBio presents novel ADCs for cancer treatment

April 29, 2022

Study finds targets of T-cell response in multiple sclerosis

April 28, 2022

Allogeneic NK-cell therapy CAT-179 useful for controlling HER2-positive tumors

April 28, 2022

AT-0174 IDO/TDO dual inhibitor shows promise for treating platinum-resistant NSCLC

April 28, 2022

Herantis reports blood-brain barrier penetration data with HER-096 in dogs

April 28, 2022

Medy-Tox patents new BTK inhibitors

April 28, 2022

University of Texas System identifies CBP and/or p300 inhibitors

April 28, 2022

Humanwell Healthcare presents new P2X3 receptor antagonists

April 28, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.